Indium111PentetreotideQualityChecker

Indium-111 Pentetreotide

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity In-111
Open selection

Utility description: Indium-111 Pentetreotide

Indium-111 Pentetreotide Quality Checker — Indium-111 Pentetreotide (OctreoScan®)

ℹ️  Utility checks critical parameters of the somatostatin analog radiopharmaceutical:
    • Radiochemical purity (≥90%)
    • Free Indium-111 impurity (≤5%)
    • Colloidal Indium-111 impurity (≤5%)
    • Specific activity (30–60 MBq/μg)
    • pH (4.0–6.0), endotoxins, sterility, heavy metals

⚠️  CRITICAL: Free Indium-111 accumulates in bone marrow and liver!
    Colloidal Indium-111 is taken up by the reticuloendothelial system (liver/spleen)!
    This creates high physiological background, masking GI and pancreatic tumors.

Usage:
  Indium111PentetreotideQualityChecker.exe                            → demo mode (console output)
  Indium111PentetreotideQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial

Example (sterility: 0=sterile, 1=contaminated):
  IN111-PEN-2026-001,94.5,2.5,3.0,45.0,5.2,80.0,0,3,50.0

— WHY IS THIS NEEDED?
Indium-111 Pentetreotide (OctreoScan®) is a radiopharmaceutical for scintigraphy of neuroendocrine tumors (NETs).
• Indium-111 (T½=2.8 days) emits gamma rays (171 and 245 keV).
• Pentetreotide is a synthetic somatostatin analog binding to somatostatin receptors (subtypes 2 and 5) expressed on most NETs.
• "Gold standard" for diagnosing carcinoids, gastrinomas, glucagonomas, etc.

⚠️  CRITICAL:
• Radiochemical purity ≥90% — ensures specific binding to the tumor.
• Free Indium-111 ≤5% — unbound indium gives signal in bones and liver.
• Colloidal Indium-111 ≤5% — hydrolyzed indium is taken up by liver and spleen, which is critical as many NETs are located in this area.
• pH 4.0–6.0 — product is stable in acidic environment (presence of gentisic acid stabilizer).
• Endotoxins ≤175 EU/vial — safety standard.
• Sterility — MANDATORY!

Key features:
• Separate control of free and colloidal indium.
• Specific activity control to ensure high image-to-background contrast.
• Specific pH range for peptide product.

Critical parameters:
• Radiochemical purity: ≥90.0%
• Free Indium-111: ≤5.0%
• Colloidal Indium-111: ≤5.0%
• Specific activity: 30–60 MBq/μg
• pH: 4.0–6.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm

💡 Usage tips:
1. RCP is determined by TLC.
2. System 1 (ITLC-SG, 0.1 M citric acid): Free In-111 moves with solvent front (Rf=1.0), Conjugate and Colloid stay at origin (Rf=0.0).
3. System 2 (ITLC-SG, 10% NH4OAc:MeOH 1:1): Colloid stays at origin (Rf=0.0), Conjugate and Free move (Rf=1.0).
4. Calculation: % Conjugate = 100% - (% Free + % Colloid).
5. The product must be used within 24 hours after labeling.

⚠️ Note: Pentetreotide is a small peptide (8 amino acids). It is rapidly cleared by kidneys. High impurity of free indium can mimic bone metastases, and colloid can mimic liver involvement. Product purity is critical for correct disease staging.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial
IN111-PEN-2026-001,94.5,2.5,3.0,45.0,5.2,80.0,0,3,50.0
IN111-PEN-2026-002,89.0,6.0,5.0,42.0,5.5,90.0,0,4,50.0

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Indium111PentetreotideQualityChecker for Indium-111 Pentetreotide.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of the somatostatin analog radiopharmaceutical:
  • • Radiochemical purity (≥90%)
  • • Free Indium-111 impurity (≤5%)
  • • Colloidal Indium-111 impurity (≤5%)
  • • pH (4.0–6.0), endotoxins, sterility, heavy metals
  • ⚠️ CRITICAL: Free Indium-111 accumulates in bone marrow and liver!
  • BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥90% — ensures specific binding to the tumor.
  • • Free Indium-111 ≤5% — unbound indium gives signal in bones and liver.
  • • Colloidal Indium-111 ≤5% — hydrolyzed indium is taken up by liver and spleen, which is critical as many NETs are located in this area.
  • • Endotoxins ≤175 EU/vial — safety standard.
  • • Sterility — MANDATORY!

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Indium-111 Pentetreotide using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringIN111-PEN-2026-001Batch or lot identifier used for traceability.
2RadiochemicalPurityPercentstring94.5Radiochemical purity; confirms the labelled chemical form and binding quality.
3FreeIndium111Percentdecimal2.5Free radionuclide / unbound species; important for non-target uptake and toxicity.
4ColloidalIndium111Percentstring3.0Controlled input parameter used by the deterministic QC rules.
5SpecificActivityMBqPerUgdecimal45.0Radioactivity value used for release, decay or dose-related assessment.
6pHdecimal5.2Solution pH; relevant for stability, compatibility and administration.
7EndotoxinsEUdecimal80.0Bacterial endotoxins; critical for parenteral administration.
8SterilityTestflag / boolean0Sterility result; critical release parameter.
9HeavyMetalsPPMdecimal3Elemental impurity / metal residue parameter.
10PeptideConcentrationUgPerVialstring50.0Controlled input parameter used by the deterministic QC rules.
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial
IN111-PEN-2026-001,94.5,2.5,3.0,45.0,5.2,80.0,0,3,50.0
IN111-PEN-2026-002,89.0,6.0,5.0,42.0,5.5,90.0,0,4,50.0

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Indium-111 Pentetreotide, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "indium111-pentetreotide-quality-checker",
  "api": "Indium-111 Pentetreotide",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "IN111-PEN-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "94.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeIndium111Percent",
      "value": "2.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ColloidalIndium111Percent",
      "value": "3.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificActivityMBqPerUg",
      "value": "45.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "5.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "80.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SterilityTest",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Diabetes QC Suite

QC package for diabetes medicines: insulins, metformin, SGLT2/DPP-4/GLP-1 products, glucagon and supporting dosage-form quality checks.

Open

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Neurology QC Suite

QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: labelled cells and blood

In-111 and Cr-51 for labelled cells, blood volume, RBC/WBC and survival workflows.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH use case: PET/SPECT oncology diagnostics and receptor imaging

F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open